523 related articles for article (PubMed ID: 17070596)
1. Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study.
; Miglior S; Pfeiffer N; Torri V; Zeyen T; Cunha-Vaz J; Adamsons I
Ophthalmology; 2007 Jan; 114(1):3-9. PubMed ID: 17070596
[TBL] [Abstract][Full Text] [Related]
2. Intercurrent factors associated with the development of open-angle glaucoma in the European glaucoma prevention study.
Miglior S; Torri V; Zeyen T; Pfeiffer N; Vaz JC; Adamsons I;
Am J Ophthalmol; 2007 Aug; 144(2):266-275. PubMed ID: 17543874
[TBL] [Abstract][Full Text] [Related]
3. Results of the European Glaucoma Prevention Study.
Miglior S; Zeyen T; Pfeiffer N; Cunha-Vaz J; Torri V; Adamsons I;
Ophthalmology; 2005 Mar; 112(3):366-75. PubMed ID: 15745761
[TBL] [Abstract][Full Text] [Related]
4. The association between glaucomatous visual fields and optic nerve head features in the Ocular Hypertension Treatment Study.
Keltner JL; Johnson CA; Anderson DR; Levine RA; Fan J; Cello KE; Quigley HA; Budenz DL; Parrish RK; Kass MA; Gordon MO;
Ophthalmology; 2006 Sep; 113(9):1603-12. PubMed ID: 16949445
[TBL] [Abstract][Full Text] [Related]
5. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.
Krupin T; Liebmann JM; Greenfield DS; Rosenberg LF; Ritch R; Yang JW;
Ophthalmology; 2005 Mar; 112(3):376-85. PubMed ID: 15745762
[TBL] [Abstract][Full Text] [Related]
6. The European glaucoma prevention study design and baseline description of the participants.
Miglior S; Zeyen T; Pfeiffer N; Cunha-Vaz J; Torri V; Adamsons I;
Ophthalmology; 2002 Sep; 109(9):1612-21. PubMed ID: 12208707
[TBL] [Abstract][Full Text] [Related]
7. Predictors of long-term progression in the early manifest glaucoma trial.
Leske MC; Heijl A; Hyman L; Bengtsson B; Dong L; Yang Z;
Ophthalmology; 2007 Nov; 114(11):1965-72. PubMed ID: 17628686
[TBL] [Abstract][Full Text] [Related]
8. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.
Bengtsson B; Leske MC; Hyman L; Heijl A;
Ophthalmology; 2007 Feb; 114(2):205-9. PubMed ID: 17097736
[TBL] [Abstract][Full Text] [Related]
9. Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma.
Parisi V; Miglior S; Manni G; Centofanti M; Bucci MG
Ophthalmology; 2006 Feb; 113(2):216-28. PubMed ID: 16406535
[TBL] [Abstract][Full Text] [Related]
10. The Heidelberg retina tomograph ancillary study to the European glaucoma prevention study: study design and baseline factors.
Hoffmann EM; Miglior S; Zeyen T; Torri V; Rulli E; Aliyeva S; Floriani I; Cunha-Vaz J; Pfeiffer N
Acta Ophthalmol; 2013 Dec; 91(8):e612-9. PubMed ID: 23710686
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of heidelberg retina tomograph parameters for the development of glaucoma in the European glaucoma prevention study.
Miglior S; Zeyen T; Hoffmann EM; Torri V; Rulli E; Floriani I; Poli D; Aliyeva S; Cunha-Vaz J; Pfeiffer N
Am J Ophthalmol; 2015 Feb; 159(2):265-76.e1. PubMed ID: 25448996
[TBL] [Abstract][Full Text] [Related]
12. Baseline risk factors for the development of primary open-angle glaucoma in the Ocular Hypertension Treatment Study.
Coleman AL; Gordon MO; Beiser JA; Kass MA;
Am J Ophthalmol; 2004 Oct; 138(4):684-5. PubMed ID: 15488816
[TBL] [Abstract][Full Text] [Related]
13. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
Martínez A; Sánchez M
Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
[TBL] [Abstract][Full Text] [Related]
14. Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension.
; ; Gordon MO; Torri V; Miglior S; Beiser JA; Floriani I; Miller JP; Gao F; Adamsons I; Poli D; D'Agostino RB; Kass MA
Ophthalmology; 2007 Jan; 114(1):10-9. PubMed ID: 17095090
[TBL] [Abstract][Full Text] [Related]
15. Silent cerebral infarct and visual field progression in newly diagnosed normal-tension glaucoma: a cohort study.
Leung DY; Tham CC; Li FC; Kwong YY; Chi SC; Lam DS
Ophthalmology; 2009 Jul; 116(7):1250-6. PubMed ID: 19481813
[TBL] [Abstract][Full Text] [Related]
16. The accuracy and clinical application of predictive models for primary open-angle glaucoma in ocular hypertensive individuals.
Ocular Hypertension Treatment Study Group and the European Glaucoma Prevention Study Group
Ophthalmology; 2008 Nov; 115(11):2030-6. PubMed ID: 18801578
[TBL] [Abstract][Full Text] [Related]
17. Comparison of optic nerve head topography and visual field in eyes with open-angle and angle-closure glaucoma.
Boland MV; Zhang L; Broman AT; Jampel HD; Quigley HA
Ophthalmology; 2008 Feb; 115(2):239-245.e2. PubMed ID: 18082888
[TBL] [Abstract][Full Text] [Related]
18. [Glaucoma and ocular hypertension: the importance of intraocular pressure in treatment decisions in France].
Bron A; Nordmann JP; Baudouin C; Rouland JF; Kadi A; Sartral M
J Fr Ophtalmol; 2003 Nov; 26(9):895-903. PubMed ID: 14631273
[TBL] [Abstract][Full Text] [Related]
19. Associations between elevated intraocular pressure and glaucoma, use of glaucoma medications, and 5-year incident cataract: the Blue Mountains Eye Study.
Chandrasekaran S; Cumming RG; Rochtchina E; Mitchell P
Ophthalmology; 2006 Mar; 113(3):417-24. PubMed ID: 16458969
[TBL] [Abstract][Full Text] [Related]
20. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
Bournias TE; Lai J
Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
